Endo International | Fremdkapital



Loan Capital Veränderung Datum
AbbVie USD 60.34B 1.83B 2024-12
Amarin USD 0 0 2025-03
ANI Pharmaceuticals USD 611.63M 3.29M 2025-03
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Eli Lilly USD 34.5B 5.97B 2025-03
Hikma Pharmaceutical USD 607M 454M 2024-12
Ligand Pharmaceuticals USD 0 0 2025-03
Merck USD 33.48B 978M 2025-03
Novartis USD 22.93B 2.41B 2024-12
Pacira USD 381.29M 2.26M 2025-03
Perrigo USD 3.59B 9.6M 2025-03
Pfizer USD 57.64B 234M 2025-03
Supernus Pharmaceuticals USD 0 0 2024-12
Takeda JPY 3.97T 738.36B 2025-03
Teva Pharmaceutical Industries USD 16.23B 228M 2025-03
Xeris Pharmaceuticals USD 217.01M 779K 2024-12
Zoetis USD 5.23B 7M 2025-03



Endo International Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.